Back
Compare AU
Compare DRUG vs. QPON
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares Global Healthcare Currency Hedged ETF (DRUG) and the Betashares Australian Bank Senior Floating Rate Bond ETF (QPON). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | QPON | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 71 | 27 |
Median incremental investment | $755.79 | $3,022.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,071.76 | $3,377.22 |
Average age group | > 35 | > 35 |
Key Summary
DRUG | QPON | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | QPON.AX was created on 2017-06-01 by BetaShares. The fund's investment portfolio concentrates primarily on high yield fixed income. QPON.AX aims to track the performance of an index (before fees and expenses) that measures the performance of a portfolio of some of the largest and most liquid senior floating rate bonds issued by Australian banks. |
Top 3 holdings | MYR - MALAYSIAN RINGGIT (0 %) HKD - HONG KONG DOLLAR (0 %) USD - UNITED STATES DOLLAR (0 %) | AUSTRALIA & NEW ZEALAND BANKING GROUP LTD FRN FEB-30 (10.72 %) COMMONWEALTH BANK OF AUSTRALIA FRN AUG-30 (10.05 %) NATIONAL AUSTRALIA BANK LTD FRN MAR-30 (10.01 %) |
Top 3 industries | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) | Other (96.47 %) Communication Services (3.53 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.57 % | 0.22 % |
Key Summary
DRUG | QPON | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Solactive Australian Bank Senior Floating Rate Bond Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.22 % |
Price | $8.91 | $26.18 |
Size | $185.929 million | $1.857 billion |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.81 % | 2.57 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 06/06/2017 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | QPON | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 71 | 27 |
Median incremental investment | $755.79 | $3,022.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,071.76 | $3,377.22 |
Average age group | > 35 | > 35 |
Pros and Cons
DRUG | QPON | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | QPON |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |